Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
RXi Pharmaceuticals Corporation (RXi) is a biotechnology company that discovers, develops and commercializes therapies based on RNAi platform. The company's products include RXI-109 and Samcyprone gel. Its RXI-109 is an RNAi compound, which is used to reduce the expression of critical regulator of several biological pathways in fibrosis such as scar formation in the skin. RXi offers products for the treatment of anti scarring, macular degeneration, retinoblastoma, and liver diseases. The company uses RNAi and sd-rxRNA technologies for the development of products. It works in partnership with academia, biotech, and large multi-national organizations for the development of new therapeutics. RXi is headquartered in Marlborough, Massachusetts, the US.
RXi Pharmaceuticals Corporation Key Recent Developments
Aug 11, 2016: RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments
May 12, 2016: RXi Pharmaceuticals Reports First Quarter 2016 Financial Results and Highlights Recent Corporate Developments
May 10, 2016: RXi Pharmaceuticals Provides Strategic Update
May 04, 2016: RXi Pharmaceuticals to Present an Update on its Consumer Health Programs at the Society for Investigative Dermatology 75th Annual Meeting
May 02, 2016: RXi Pharmaceuticals Secures European Patent for Novel RNAi Platform
This comprehensive SWOT profile of RXi Pharmaceuticals Corporation provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RXi Pharmaceuticals Corporation including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
RXi Pharmaceuticals Corporation-Key Information
RXi Pharmaceuticals Corporation-Overview
RXi Pharmaceuticals Corporation-Key Employees
RXi Pharmaceuticals Corporation-Key Employee Biographies
RXi Pharmaceuticals Corporation-Key Operational Heads
RXi Pharmaceuticals Corporation-Major Products and Services
RXi Pharmaceuticals Corporation-History
RXi Pharmaceuticals Corporation-Company Statement
RXi Pharmaceuticals Corporation-Locations And Subsidiaries
RXi Pharmaceuticals Corporation-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
RXi Pharmaceuticals Corporation-Business Description
RXi Pharmaceuticals Corporation-Corporate Strategy
RXi Pharmaceuticals Corporation-SWOT Analysis
RXi Pharmaceuticals Corporation-Strengths
RXi Pharmaceuticals Corporation-Weaknesses
RXi Pharmaceuticals Corporation-Opportunities
RXi Pharmaceuticals Corporation-Threats
RXi Pharmaceuticals Corporation-Key Competitors
Section 3-Company Financial Performance Charts
RXi Pharmaceuticals Corporation-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
RXi Pharmaceuticals Corporation, Performance Chart
RXi Pharmaceuticals Corporation, Ratio Charts
List of Tables
RXi Pharmaceuticals Corporation, Key Information
RXi Pharmaceuticals Corporation, Key Ratios
RXi Pharmaceuticals Corporation, Share Data
RXi Pharmaceuticals Corporation, Major Products and Services
RXi Pharmaceuticals Corporation, History
RXi Pharmaceuticals Corporation, Key Employees
RXi Pharmaceuticals Corporation, Key Employee Biographies
RXi Pharmaceuticals Corporation, Key Operational Heads
RXi Pharmaceuticals Corporation, Other Locations
RXi Pharmaceuticals Corporation, Subsidiaries
RXi Pharmaceuticals Corporation, Key Manufacturing facilities
RXi Pharmaceuticals Corporation, Key Competitors
RXi Pharmaceuticals Corporation, SWOT Analysis
RXi Pharmaceuticals Corporation, Ratios based on current share price
RXi Pharmaceuticals Corporation, Annual Ratios
RXi Pharmaceuticals Corporation, Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
RXi Pharmaceuticals Corporation, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts